Impaired fatty acid metabolism is associated with heart failure (HF) prognosis. However, specific changes in acylcarnitine profiles and their potential clinical value have not been well explored in patients recovering from acute decompensation.
This study recruited 79 HF patients hospitalized because of acute decompensation with a left ventricular ejection fraction (LVEF) of < 40% and 51 normal controls. Patients were dichotomized into two groups, namely, the \"improved (IMP) \" and the \"non-improved (NIMP) \" groups, as defined by the changes in LVEF from baseline to 12 months after discharge. Mass spectrometry was used to quantify the acylcarnitine concentrations at baseline and 6 and 12 months after discharge. The IMP and NIMP groups contained 42 and 37 patients, respectively. At baseline, HF patients had higher plasma concentrations of specific long-, medium-, and short-chain acylcarnitines compared to normal controls. From baseline to 12 months post-discharge, the IMP group showed significant decreases in long- and short-chain acylcarnitine concentrations, but significant increases in medium-chain acylcarnitines. In the NIMP group, none of the acylcarnitines significantly decreased, and significant increases were noted in long-, medium-, and short-chain acylcarnitines. Generalized estimating equations demonstrated that nine acylcarnitines could discriminate the IMP group from the NIMP group, including three long-chain (C18:1, C16, and C16:1) and six short-chain acylcarnitines (C5, C5-OH, C4, C4:1-DC, C3, and C2). After adjusting for age, the six short-chain acylcarnitines remained significant. Changes in short-chain acylcarnitine profiles are independently associated with the improvement in cardiac systolic function after acute decompensation.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410004222624763136","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000410298973"}],"foaf:name":[{"@language":"en","@value":"Chen Wei-Siang"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Chang Gung University College of Medicine"}]},{"@id":"https://cir.nii.ac.jp/crid/1410004222624763138","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000410298974"}],"foaf:name":[{"@language":"en","@value":"Liu Min-Hui"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Chang Gung University College of Medicine"}]},{"@id":"https://cir.nii.ac.jp/crid/1410004222624763137","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000410298975"}],"foaf:name":[{"@language":"en","@value":"Cheng Mei-Ling"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Healthy Aging Research Center, Chang Gung University"},{"@language":"en","@value":"Metabolomics Core Laboratory, Chang Gung University"},{"@language":"en","@value":"Department of Biomedical Sciences, Chang Gung University College of Medicine"}]},{"@id":"https://cir.nii.ac.jp/crid/1410004222624763139","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000410298976"}],"foaf:name":[{"@language":"en","@value":"Wang Chao-Hung"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Chang Gung University College of Medicine"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13492365"},{"@type":"LISSN","@value":"13492365"},{"@type":"EISSN","@value":"13493299"}],"prism:publicationName":[{"@language":"en","@value":"International Heart Journal"},{"@language":"en","@value":"Int. Heart J."}],"dc:publisher":[{"@language":"en","@value":"International Heart Journal Association"},{"@language":"ja","@value":"一般社団法人 インターナショナル・ハート・ジャーナル刊行会"}],"prism:publicationDate":"2020-09-29","prism:volume":"61","prism:number":"5","prism:startingPage":"1014","prism:endingPage":"1021"},"reviewed":"false","url":[{"@id":"https://www.jstage.jst.go.jp/article/ihj/61/5/61_20-053/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2021199267"}],"availableAt":"2020-09-29","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Fatty%20acid","dc:title":"Fatty acid"},{"@id":"https://cir.nii.ac.jp/all?q=Lipidomics","dc:title":"Lipidomics"},{"@id":"https://cir.nii.ac.jp/all?q=Metabolism","dc:title":"Metabolism"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011145561959424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Acylcarnitines—old actors auditioning for new roles in metabolic physiology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145799044608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095351808512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial dysfunction in pathophysiology of heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095477167232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolic Biomarkers in Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570162238592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The response of canine faecal microbiota to increased dietary protein is influenced by body condition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570772551296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Highly viscous guar gum shifts dietary amino acids from metabolic use to fermentation substrate in domestic cats"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995909103872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Amino Acid-Based Metabolic Profile Provides Functional Assessment and Prognostic Value for Heart Failure Outpatients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468838937088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418517236608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420821037696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544421276248832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893940380672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intestinal fermentation modulates postprandial acylcarnitine profile and nitrogen metabolism in a true carnivore: the domestic cat (Felis catus)"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895455680128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895873968384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Acylcarnitines"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368706372864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369428438400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845702329042304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2008055360"},{"@type":"CROSSREF","@value":"10.1536/ihj.20-053"},{"@type":"PUBMED","@value":"32879261"},{"@type":"CIA","@value":"130007911330"}]}